Understanding Adenomyosis: A Guide for English-Speaking Expats Living in Paris

For many English-speaking expats living in Paris, it can be challenging to navigate a different healthcare system while also trying to understand gynecologic conditions like adenomyosis and endometriosis. This article explains what adenomyosis is, how it relates to endometriosis, how it is diagnosed, and which treatment options are available—including medical treatments, uterine artery embolization, and hysterectomy using minimally invasive techniques.

What Is Adenomyosis?

Adenomyosis is a benign (non-cancerous) condition where tissue similar to the lining of the uterus (endometrium) grows inside the muscular wall of the uterus (the myometrium). Under the microscope, it is defined by endometrial glands and stroma located within the myometrium, often with thickening of the surrounding muscle.

Histologic vs. Clinical Diagnosis

Strictly speaking, adenomyosis is a histologic diagnosis—the gold standard has traditionally been examining the uterus after hysterectomy under the microscope.

However, we obviously do not remove most women’s uteri just to get a diagnosis!  In daily practice, especially for women who wish to preserve fertility or their uterus, we rely on a combination of clinical symptoms such as heavy periods, painful periods, chronic pelvic pain, bloating, painful intercourse, and fertility issues, and imaging (transvaginal ultrasound and/or MRI).

So while “definitive” diagnosis is histological, most modern diagnoses are made based on imaging plus symptoms, using internationally accepted criteria.

Relationship to Endometriosis

Adenomyosis can be thought of as a subset of endometriosis since its underlying pathology stems from the same problem: endometrial tissue that migrates to a location is shouldn’t go to! In Endometriosis we often see these endometrial cells move from the inside of the uterus (endometrium) to parts outside the uterus such as the ovaries, pelvic peritoneum, bowel, bladder, and even more distant locations in the worst of cases. In Adenomyosis, these endometrial cells go into the uterine muscle (myometrium) and embed themselves there (see image below), causing localized inflammation, disruption the contractility of the myometrium and increasing its size many times.

When we understand that the underlying cause is the same, we understand why many treatment options also overlap.

Types of Adenomyosis

There have been multiple prior attempts to implement a classification system for adenomyosis, but none have really taken off or correlated with clinical symptoms. However, for practical purposes, especially when considering surgical interventions, a simple classification can be helpful:

  • Diffuse – widespread involvement of the uterine muscle
  • Focal – more localized areas of disease

When adenomyosis is focal and forms a discrete mass-like lesion, this may be called an adenomyoma. An adenomyoma is essentially a nodular lump of adenomyosis: endometrial tissue embedded in a ball of thickened uterine muscle, and it can sometimes be mistaken for a fibroid on imaging.

These focal adenomyomas can cause heavy bleeding and pain—similar to diffuse adenomyosis—but sometimes lend themselves to more targeted surgical approaches such as removal or radiofrequency ablation of the mass with preservation of the uterus.

https://link.springer.com/chapter/10.1007/174_2017_146/figures/4

Diagnosis and Imaging – Why MRI Is Helpful (and Affordable in France)

While transvaginal ultrasound is often the first test done in many countries, MRI is considered the best imaging modality for deeper forms of endometriosis and adenomyosis. Although studies comparing sensitivity and specificity (how good a test is at detecting a condition or not) between ultrasounds and MRIs have been mixed, the truth is that an ultrasound result depends on how good and experienced the sonographer is at detecting adenomyosis. MRI is a more objective test, and can better distinguish between soft tissues. Additionally, it examines the entire pelvis, so we can identify if there are areas of endometriosis (specially superficial implants) that are not easily seen on ultrasound.

The biggest drawback to MRI has historically been cost, which in places like the United States can be a couple of thousand dollars. Thankfully, this test in France is much more affordable and covered by insurance, whether it’s French social security or international insurance. Even without insurance, the out-of-pocket price for this test is around 250 euros. For many expats (and doctors like myself) used to the healthcare system in the United States, this is a pleasant surprise!  

A word on perimenopause and menopause

During perimenopause, hormone levels fluctuate and cycles can become irregular, heavy or prolonged.

If you already have underlying adenomyosis—even if it was silent before—these hormonal changes can unmask or worsen symptoms, particularly heavy bleeding and cramping. Many women present during this time with iron deficiency anemia caused by heavy bleeding, in addition to new onset pain that they thought was behind them. If this happens, make sure to seek consultation to obtain a diagnosis of why these new symptoms are happening and discuss possible treatment options. 

Adenomyosis and Hormone Replacement Therapy (HRT)

Hormonal therapy with estrogens is often utilized to relieve symptoms of perimenopause and menopause, as well as to provide the medical benefits. However, estrogens can sometimes flare adenomyosis or unmask bleeding from adenomyosis, especially if the progestogen component of HT is not fully suppressing the lining. If you notice new or heavier bleeding on HRT, it is important to discuss with your gynecologist, possible obtain imaging to rule out adenomyosis, fibroids, polyps, or other pathology, and consider an alternative progestogen component, such as hormonal IUDs.

Treatment Options for Adenomyosis

There is no single “best” treatment. The approach depends on:

  • Your age and symptoms
  • Whether you want to preserve fertility or the uterus
  • Your tolerance for hormones or surgery

In general, we start with medical management, then consider uterus-sparing procedures such as uterine artery embolization, and finally definitive surgery (hysterectomy) if symptoms remain severe.

Medical Management

1. Non-Hormonal Options

a) NSAIDs (ibuprofen, ketoprofene, naproxen, etc.)

How they work:
NSAIDs block prostaglandins, chemicals that cause uterine contractions and pain, reducing menstrual cramps and sometimes modestly reducing bleeding.

Effectiveness:
These medications can work very well for painful periods if taken correctly: ideally they should started 2 days before the onset of menses and continuing through the days of bleeding. However, for management of heavy bleeding due to adenomyosis, they are not as effective. They should be combined with another method.

Pros:

  • Non-hormonal (if you are looking to avoid hormones)
  • Can be used while trying to conceive
  • Available without prescription, widely available, inexpensive
  • Can be combined with other methods

Cons:

  • Do not treat the underlying adenomyosis
  • Can cause stomach irritation or, rarely, kidney/cardiovascular side effects
  • Often insufficient alone if looking to address heavy bleeding

b) Tranexamic Acid (TXA)

How it works:
Tranexamic acid is an antifibrinolytic: it stabilizes blood clots in the endometrium so less blood is lost during menstruation.

Effectiveness:
Randomized controlled trials in patients who suffer from heavy menstrual bleeding (no matter the cause) have shown about a 34–40% reduction in menstrual blood loss compared with baseline and placebo. It is usually used for a maximum of 5 days per month, during the heaviest days of bleeding. However, TXA is not as effective as treating pain, so this can often be paired with NSAIDs (see above), to provide both pain relief and minimize bleeding.

Pros:

  • Non-hormonal (if you are looking to avoid hormones)
  • Taken only on heavy days of the period
  • Can be combined with other treatments

Cons:

  • Mainly reduces bleeding, not pain
  • Not suitable in women with certain clotting or thrombotic risks
  • Data in adenomyosis specifically are more limited (but it is widely used in practice)

2. Hormonal Therapies

Because adenomyosis is hormone-responsive, hormonal treatments aim to:

  • Thin the uterine lining
  • Reduce estrogen stimulation
  • Decrease inflammatory activity in adenomyotic tissue

a) Levonorgestrel-Releasing Intrauterine Device (“Hormonal IUD” aka Mirena)

How it works:
The device releases levonorgestrel directly into the uterine cavity, which:

  • Thins and stabilizes the endometrium
  • Reduces local blood flow
  • Creates a progestin-dominant environment that suppresses adenomyotic foci and may shrink the uterus slightly

Effectiveness:

  • Systematic reviews show significant improvement in heavy bleeding and pain for the majority of women with adenomyosis, with around 70–90% reporting symptom relief and reductions in uterine volume over 1–3 years.

Pros:

  • Helps with both pain and bleeding.
  • Long-acting (For Mirena, up to 5 years for hormonal use, 7 years for contraception)
  • Avoids taking daily pills
  • Strong evidence in adenomyosis
  • Locally acting means low hormonal levels systemically (about one tenth of the dose found in oral pills is found in circulating blood)
  • Reliable contraception

Cons:

  • Irregular spotting in the first months
  • Not suitable for everyone (uterine cavity shape due to large fibroids may make it difficult to place and have higher chance of expulsion)
  • A minority of women have insufficient response (possible progesterone resistance)

b) Combined Oral Contraceptive Pills (aka “Birth control pill”)

How it works:

We call it the combined pill because it has both an estrogen and a progestin component. There are over 100 formulations of it based on type of estrogen, type of progestin, dose, number of days, etc, so it’s not a “one size fits all” type of medication and it may take time finding the right one for you. Of all the methods listed here, this is the only one that reliably suppresses ovulation and can be used in the long term (the other being GnRH agonists, see below).

Because it puts the ovaries “to sleep”, and the hormonal fluctuations due to ovulation don’t happen, it can also help with cases of ovarian cysts, PMS, or irregular bleeding. In the case of adenomyosis, it helps by thinning and stabilizing the endometrium, as well as endometrial tissue found elsewhere. The pill can also be taken continuously (without placebo) to reduce the number of withdrawal bleeds if we are trying to address anemia or heavy bleeding.

Effectiveness:
Data are stronger for endometriosis than adenomyosis, but many women see a 50–70% improvement in pain and bleeding, especially with continuous use.

Pros:

  • Familiar option
  • Regulates or suppresses periods
  • Provides contraception

Cons:

  • Because it contains estrogen, it is not recommended for use in certain patients (those with migraine with aura, at increased risk of blood clots, smokers, etc).
  • Breakthrough bleeding can still occur in adenomyosis
  • Some patients experience mood or breast symptoms

c) Oral Progestins (e.g. Dienogest, Desogestrel, Drospirenone, etc)

How they work:

These pills are taken daily and only contain one type of hormone –progestins (as opposed to the combined pills discussed above). They work by:

  • Creating a progestin-dominant, relatively hypoestrogenic environment
  • Suppressing endometrial proliferation and the activity of the adenomyosis implants
  • Reduce prostaglandins and inflammation

Effectiveness:
Progestins such as dienogest are well studied in endometriosis and increasingly in adenomyosis, improving pain and bleeding scores and quality of life.

Pros:

  • Estrogen-free
  • Can be used long-term
  • Often effective in both pain and bleeding control

Cons:

  • Irregular spotting, mood changes, bloating, and reduced libido are possible
  • Long-term high-dose exposure to certain progestins may be linked to meningioma risk (see below for injectables and French context)

d) Injectable Progesterone – Depo Provera (Depot Medroxyprogesterone Acetate, DMPA)

How it works:

  • A progesterone injection given every 3 months
  • Thins the endometrium and can suppress ovulation in some patients
  • Reduces estrogen levels enough to quiet endometriosis/adenomyosis lesions and significantly decrease bleeding

Effectiveness:

  • DMPA is approved for endometriosis-related pain and has been shown to be as effective as GnRH agonists (e.g., leuprolide) for pain relief, with fewer hot flushes and less bone loss.
  • Although data are mainly in endometriosis, the same mechanism is relevant to adenomyosis, and many women experience major improvement in pain and heavy bleeding.

French context – meningioma risk:

  • Recent large epidemiologic studies (including French Epi-Phare data published in the BMJ) found that prolonged use of injectable medroxyprogesterone acetate is associated with an increased risk of intracranial meningioma, with relative risk around 5.6 after long-term exposure.
  • Because of this, Depo Provera is less commonly used in France and is prescribed with caution, especially in women over 35–40 or with neurological symptoms. If a patient is on it, protocols in France now recommend obtaining surveillance MRIs of the brain if there are neurological symptoms.

Pros:

  • Very convenient (one injection every 3 months)
  • No need to remember daily pills
  • Effective contraception
  • No estrogen component

Cons:

  • Irregular bleeding and eventual amenorrhea (no periods) are common
  • Can be associated with weight gain and mood changes in some women (average 3lbs in studies)
  • Delayed return of fertility after stopping
  • Long-term use is now monitored more closely in France because of the meningioma signal; not suitable if you have a known meningioma, and caution is needed in long-duration use

Despite these concerns, it remains an available and sometimes very useful option, particularly for women who prefer an injection every three months rather than daily tablets, after an informed discussion of risks and benefits.

e) Etonogestrel Implant (Nexplanon)

How it works:

  • A small rod inserted under the skin of the upper arm under local anesthesia in the office
  • Releases etonogestrel (a progesterone) continuously for up to 3 years
  • Suppresses ovulation in many women and thins the endometrium

Effectiveness:

  • Recent studies show that etonogestrel implants can significantly improve dysmenorrhea and menstrual disorders in women with endometriosis and adenomyosis, with sustained benefit over several years.
  • In one study of women with endometriosis-associated pelvic pain, etonogestrel implants were not inferior to the Mirena IUD for relief of non-cyclic pelvic pain and dysmenorrhea.

Pros:

  • Long-acting (3-4 years)
  • Estrogen-free
  • Very little daily maintenance—ideal for women who do not want to take a daily pill
  • Highly effective contraception

Cons:

  • Irregular, unpredictable bleeding is common (and can be bothersome in adenomyosis)
  • Some women experience mood changes, acne, or breast tenderness
  • Can be trickier to gauge uterine bleeding patterns because there is no standard “cycle”

f) GnRH Agonists/Antagonists

How they work:

  • Temporarily switch off ovarian estrogen production by interfering with the signals between the brain and the ovary, creating a reversible “medical menopause”
  • Strongly suppress adenomyosis and endometriosis activity.
  • Traditionally was given as an injection (Leuprolide/Leuproreline), but recently an oral formulation (Relugolix) was approved in France which can be used long term and is intended for patients who have already tried first line agents like progestin therapy and still have symptoms.

Effectiveness:

  • Very effective (close to 100%) for pain and bleeding while on treatment, after an initial “flare” in symptoms.
  • Commonly used as second-line therapy, or as a short-term “bridge” before surgery or fertility treatment.

Pros:

  • Powerful symptom control in severe cases
  • Can reduce uterine size and help optimize surgical timing

Cons:

  • Menopausal symptoms (hot flushes, night sweats, vaginal dryness, mood changes)
  • Bone density loss with prolonged use; usually limited to 3–6 months unless combined with “add-back” low-dose hormones
  • Symptoms often recur after stopping

Procedural Options

3. Uterine Artery Embolization (UAE)

What it is:
A minimally invasive radiologic procedure done by an interventional radiologist, traditionally used for fibroids but increasingly for adenomyosis.

How it works:

  • A catheter is introduced through an artery in the wrist or groin
  • Tiny particles are injected to block the blood supply to the uterus and adenomyotic areas
  • This causes shrinkage and inactivation of the adenomyotic tissue>

Effectiveness:

  • Reviews and long-term studies show:
    • Short-term symptom improvement in about 80–90% of women with adenomyosis (pure or mixed with fibroids)
    • Long-term improvement (> 3–5 years) maintained in roughly 70–80% of those who initially respond.

Pros:

  • Avoids hysterectomy in about 80% of patients.
  • No large abdominal incisions
  • Shorter recovery than hysterectomy
  • Particularly useful when surgery carries higher risk

Cons:

  • Post-embolization pain and low-grade fever are common but temporary
  • Fertility outcomes after UAE in adenomyosis remain less clear and require individual counselling
  • A minority of women eventually require further procedures or hysterectomy

4. Hysterectomy (Definitive Surgical Treatment)

What it is:
Hysterectomy is removal of the uterus, sometimes with or without the cervix. The ovaries are preserved most of the time so hormonal function or status is not affected.

How it works:

  • By removing all of the uterine muscle, the adenomyotic tissue embedded in it, and the source of menstrual bleeding are all removed.
  • When ovaries are preserved, you do not enter immediate menopause, though cycles and bleeding stop because there is no uterus.

Effectiveness:

  • Offers complete and permanent relief of heavy menstrual bleeding due to adenomyosis and very high rates of improvement in pain and pressure symptoms.

Pros:

  • Highest likelihood of definitive cure for adenomyosis-related bleeding
  • Major reduction in pain for most women
  • No further periods

Cons:

  • Requires general anesthesia and surgery
  • Removes the possibility of carrying a pregnancy
  • Standard surgical risks (bleeding, infection, injury to adjacent organs, anaesthetic risk)

Minimally Invasive Hysterectomy

Whenever possible, hysterectomy should be performed using laparoscopic, robotic-assisted, or vaginal surgery techniques:

  • Several small incisions on the abdomen (or none at all with vaginal surgery), rather than one large cut as was traditionally done
  • A camera and fine instruments—or robotic arms—are used to detach and remove the uterus, often through the vagina or via mini-incisions

Advantages compared with open surgery:

  • Smaller scars
  • Less pain after surgery
  • Shorter hospital stay
  • Faster return to daily activities
  • Better visualization of the pelvis, which is especially helpful when treating coexisting endometriosis at the same time

In certain cases of focal adenomyomas, a uterus-sparing myometrial resection (adenomyomectomy) can also be considered via laparoscopy, especially in women seeking to preserve fertility, although this depends on lesion size, location, and overall uterine integrity.

Living in Paris With Adenomyosis as an Expat

For English-speaking women living in Paris, the combination of:

  • High-quality imaging (including MRI) at relatively accessible costs
  • Expertise in endometriosis and adenomyosis
  • Access to a wide range of medical and interventional treatments
  • And advanced minimally invasive surgical techniques

means that you have many options to manage adenomyosis and improve quality of life.

If you are experiencing:

  • Heavy or painful periods
  • Worsening symptoms around perimenopause
  • New bleeding while on HRT
  • Or persistent pelvic pain

it is worth seeking a consultation with a gynecologist experienced in adenomyosis and endometriosis in expat patients. An individualized plan—sometimes combining medication, lifestyle adjustments, and, when needed, procedures such as UAE or hysterectomy—usually offers the best long-term results.

Understanding Adenomyosis: A Guide for English-Speaking Expats Living in Paris